SANOFI 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-11 10:46 am Purchase | 2020-02-13 | 13G | Fulcrum Therapeutics, Inc. FULC | SANOFI | 3,363,050 4.600% | 3,363,050 (New Position) | Filing |